Apoptosis plays an active role in the control of viral and bacterial infections (39, 42) . To establish a successful infection, pathogens developed a variety of strategies for modulating apoptosis of the host cell. Gram-negative bacteria such as Salmonella enterica serovar Typhimurium (27) , Shigella flexneri (43) , Neisseria gonorrhoeae (29) , Yersinia enterocolitica (26, 35) , and Legionella pneumophila (31) have been shown to induce apoptosis. In contrast, some obligate intracellular bacteria such as Rickettsia rickettsii (7) , Chlamydia trachomatis (10) , and Chlamydia psittaci (8) have been shown to actively block apoptosis of their host cells.
Apoptosis is initiated by two major pathways involving either cell surface receptors or mitochondria. In recent years, several death receptors, all of which belong to the tumor necrosis factor (TNF) receptor family, have been identified (2) . Ligation of these receptors results in the activation of so-called caspases, a class of cysteine proteases with a specific function in the execution of the apoptotic program. As a result of caspase activation, certain cellular substrates are cleaved and the cells undergo apoptosis (36, 40) .
Unlike the ligands of death receptors, which induce apoptosis in a well-defined way, numerous insults, toxic cell metabolites, and cytotoxic and environmental stress initiate apoptotic cell death by a less well understood pathway. Many of the signals induced by these stimuli are integrated by mitochondria. Mitochondria respond by the release of caspases or caspase-activating proteins such as cytochrome c (17) . Thus, both pathways to apoptosis finally result in the activation of caspases.
Chlamydiales represents a group of obligate intracellular bacteria that reside in a membrane-bound inclusion. Chlamydia pneumoniae has a unique biphasic developmental cycle involving two functionally and morphologically distinct forms of the bacteria, the invasive elementary bodies (EB) and the noninvasive, metabolically active reticulate bodies (RB). C. pneumoniae, first described in 1986 as a respiratory pathogen (16) , has also been implicated in the onset or progression of several nonpulmonary diseases such as atherosclerosis, reactive arthritis, and Alzheimer's disease (3, 15, 37) . In all cases of chlamydial infections, the primary site of entry is the mucosal epithelium. In vitro, C. pneumoniae completes its cycle of development in 72 to 96 h. During this time, bacteria require the integrity of host cells to support their intracellular growth and development. Recently, it has been shown that epithelial cells and macrophages infected with C. trachomatis are resistant to apoptosis induced by staurosporine, TNF-␣, granzyme B/perforin, and Fas ligand (10) . Interestingly, C. psittaci (8, 33) and C. trachomatis (10, 34) have been reported to either induce or inhibit apoptosis in the infected cells, depending on the stage of development. Geng et al. (14) have recently demonstrated that C. pneumoniae could inhibit apoptosis in the infected peripheral blood mononuclear cells, an effect that was attributed to interleukin-10 secreted in response to the chlamydial infection.
To date, whether infection with C. pneumoniae can influence apoptosis in epithelial cells, the likely site of chlamydial entry, has not been investigated. Here we demonstrate that epithelial host cells infected with C. pneumoniae are resistant to apoptosis induced by different stimuli. The potential of C. pneumoniae to prevent apoptosis largely depended on the infection conditions, suggesting a crucial role for bacterial factors produced while the pathogen multiplies in the host cells.
MATERIALS AND METHODS
Host cells and bacterial strain. The host cells were HEp-2 (ATCC CCL23), a human epithelioid cell line derived from a larynx carcinoma. The strain of C. pneumoniae used in this study was TW-183, obtained from Washington Research Foundation (Seattle, Wash.), propagated in HEp-2 cells, and purified as described previously (1) . HEp-2 cells were grown in growth medium (GM) composed of minimal essential medium (MEM) (Life Technologies, Karlsruhe, Germany) supplemented with 1% (vol/vol) nonessential amino acids (Sigma, Steinheim, Germany), 2 mM L-glutamine (Biochrom KG, Berlin, Germany), 10% (vol/vol) fetal bovine serum (FBS), 10 mM HEPES (Sigma), and 10 g of gentamicin (Sigma)/ml. All experiments involving infection with C. pneumoniae and the induction of apoptosis were performed in the infection medium composed of MEM with the same final concentration of amino acids, L-glutamine, and HEPES as in GM and supplemented with 5% (vol/vol) FBS.
Chlamydial infections. Host cells grown on coverslips in 12-or 24-well plates (Techno Plastic Products AG, Trasadingen, Switzerland) were infected using different multiplicities of infection (MOI) ranging from 0.5 to 10. The infection was performed as described previously (1) . In brief, the suspension of EB diluted in infection medium was added directly to cells and the mixture was centrifuged at 920 ϫ g for 1 h followed by incubation at 37°C for one more hour in the presence of 5% CO 2 . After the extracellular bacteria were washed away, infected cells were further incubated at 37°C in the presence of 5% CO 2 for various times after the beginning of infection. Unless otherwise mentioned, all the infections were performed in the absence of cycloheximide.
Detection of C. pneumoniae. To confirm the presence of C. pneumoniae in the infected cells, we performed staining with antichlamydia antibodies. The experiments were done at room temperature. HEp-2 cells were fixed with 4% (wt/vol) paraformaldehyde (Merck, Damstadt, Germany) in phosphate-buffered saline (PBS) (pH 7.4) for 30 min, washed twice with PBS, and permeabilized with 0.05% (vol/vol) Triton X-100 and either 2% (wt/vol) bovine serum albumin (BSA) or 10% (vol/vol) goat serum (blocking agents) in PBS. The cells were then incubated for 1 h with either the anti-C. pneumoniae major outer membrane protein (MOMP)-specific mouse monoclonal antibody used at a final dilution of 1:15 (DAKO, Hamburg, Germany) or the anti-Chlamydia genus-specific rabbit polyclonal antibody used at a dilution of 1:60 (Milan Analytica AG, La Roche, Switzerland). Unless otherwise mentioned, all antibodies were diluted in 2% (wt/vol) BSA-PBS solution. After being washed with PBS, the cells were incubated for 45 min with a rabbit anti-mouse (1:100 dilution) or goat anti-rabbit immunoglobulin G antibody coupled with Cy3 (Dianova, Hamburg, Germany) or Alexa red 548 (Molecular Probes, Leiden, The Netherlands) used at a final dilution of 1:100. The sizes of chlamydial inclusions were measured using the confocal microscope with an objective lens of 63ϫ using the Leica TCS NT software options.
Induction of apoptosis. To induce apoptosis, we used either 1 M staurosporine (Sigma) or 40 ng of TNF-␣ (Pharmingen, San Diego, Calif.)/ml, together with 2 g of cycloheximide/ml. The infected and uninfected HEp-2 cells were treated with staurosporine for 4 to 5 h and with TNF-␣ for 5 to 6 h. The control cells were incubated with cycloheximide alone. Both the stimulated and control cells were fixed with 4% paraformaldehyde in PBS for 30 min. Fixed specimens were then processed further for the analysis of apoptosis (see below).
Analysis of apoptosis. (i) Detection of chromatin condensation.
The cells that underwent induction of apoptosis were washed twice with PBS followed by permeabilization and blocking with 0.05% (vol/vol) Triton X-100 and 2% (wt/ vol) BSA or 10% (vol/vol) goat serum in PBS for 30 min. First, the staining for C. pneumoniae was performed as described above. Next, the specimens were washed twice with PBS and stained with 10 M Hoechst 33342 (Sigma) for 30 min at room temperature. After being washed three times with PBS, the coverslips were mounted onto microscope slides and evaluated for chromatin condensation and the presence of C. pneumoniae with a Leica fluorescence microscope. For each sample, cells from five random fields were counted under 400ϫ magnification. The percentage of apoptotic cells was calculated as the number of apoptotic cells divided by a total number of cells counted ϫ 100.
(ii) Annexin V assay. HEp-2 cells cultured in six-well plates were infected with C. pneumoniae EB at various MOI. At 15 h postinfection the cells in the supernatants were collected by centrifugation and counted by hemocytometer. Adherent cells were harvested by Accutase (Innovative Cell Technologies, Inc., San Diego, Calif.) treatment. Cells were washed twice with PBS and suspended in 100 l of binding buffer (10 mM HEPES-NaOH, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4). Annexin V-fluorescein isothiocyanate (FITC) (BenderMed Systems) was added, and cells were incubated for 15 min in the dark. After one wash, cells were resuspended in 200 l of binding buffer and counterstained with 1 g of propidium iodide (PI)/ml for determination of permeable (necrotic) cells. Ten thousand cells per sample were analyzed with a Becton Dickinson FACS Calibur equipped with a 15-mW, 488-nm air-cooled argon laser using FACS Express software.
(iii) Detection of caspase-3 and cytochrome c and TUNEL assay. Following the induction of apoptosis, the infected and uninfected cells were first subjected to detection of C. pneumoniae. After being washed with PBS, cells were incubated for 1 h with the rabbit polyclonal antibody specific for activated caspase-3, used at a final dilution of 1:100 (a gift from A. Srinivasan, Idun Pharmaceuticals, San Diego, Calif.). This was followed by incubation for 1 h with goat anti-rabbit immunoglobulin G coupled with DTAF (Dianova) diluted 1:100. The terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) reaction was performed using the Apoptosis Detection System, Fluorescein strictly in accordance with the manufacturer's instructions (Promega, Madison, Wis.). Cytochrome c was detected with the mouse monoclonal antibody diluted 1:100 (Pharmingen).
Quantification of cytochrome c. HEp-2 cells cultured in 75-cm 2 flasks were infected with EB at an MOI of 5. Cells at 36 h postinfection were treated with 40 ng of TNF-␣/ml and 2 g of cycloheximide/ml for 4 to 5 h to induce apoptosis. The cells in the supernatant were collected by centrifugation, and those that were adherent were collected by trypsinization. The pellet was resusupended and washed twice at 400 ϫ g with ice-cold PBS. All subsequent centrifugation steps were performed at 4°C. After another wash with MB buffer (400 mM sucrose, 50 mM Tris, 1 mM EGTA, 5 mM ␤-mercaptoethanol, 0.2% BSA, 10 mM KH 2 PO 4 , pH 7.6) the pellet was resuspended in 5 ml of MB buffer and incubated for 20 min on ice. The cells were then homogenized with 35 strokes with a Teflon homogenizer. Cell debris was removed by centrifugation at 4,000 ϫ g for 1 min, and the supernatant was centrifuged for 10 min at 15,000 ϫ g to precipitate the mitochondria. The amount of cytochrome c in the supernatant was determined using the cytochrome c enzyme-linked immunosorbent assay (ELISA) kit (Qnantikine human cytochrome c immunoassay kit; R&D Systems, Inc., Minneapolis, (Minn.) in accordance with the manufacturer's instructions. Cytochrome c was quantified using an ELISA reader (Spectra Max 250; Molecular Devices, Munich, Germany) and the Softmax Pro, version 3.0, software.
Statistics. For statistical calculations, graphs, and histograms, Microsoft Excel for Windows 7.0 was used. The error bars represent the standard deviations (SD) of the means. To determine if the observed effect is statistically significant, the Student t test was performed. P values Ͻ0.05 were considered statistically significant.
RESULTS
Epithelial cells infected with C. pneumoniae are resistant to staurosporine-induced apoptosis. To evaluate the influence of chlamydial infection on the process of apoptosis in the epithelium, we treated HEp-2 cells with staurosporine 36 h postinfection (middle stage of infection). Five hours later, chromatin condensation in infected and uninfected cells was assessed by staining with nuclear dye Hoechst 33342. The number of apoptotic cells determined by chromatin condensation was lower in the infected population than in the uninfected one. To determine the infection status of individual cells, double staining with Hoechst 33342 and an antichlamydia antibody was performed. The results demonstrated that the infected cells containing chlamydial inclusions had normal, noncondensed chromatin whereas the majority of noninfected cells had condensed chromatin (Fig. 1A) . Quantification and subsequent analyses have determined that the antiapoptotic effect was statistically significant (P ϭ 0.002) (Fig. 1B) .
To further confirm this phenomenon, we performed TUNEL, which visualizes the fragmented chromosomal DNA of apoptotic cells by incorporating fluorescein-12-dUTP at 3Ј ends of DNA. Using staurosporine as an inducer, we demonstrated a positive TUNEL reaction only in the uninfected cells. In contrast, cells with chlamydial inclusions identified by staining with a monoclonal antibody were TUNEL negative (Fig.  2) . Thus, we confirmed the lack of staurosporine-induced DNA fragmentation in the infected cells.
Inhibition of apoptosis depends on the infection conditions. The infection conditions under which apoptosis induced by staurosporine treatment was inhibited were defined. The MOI had a significant influence on the viability of the host cells. Infections at MOI ranging from 0.5 to 5 had no apparent toxic effect on the cells, whereas infections at MOI Ն10 resulted in rounding up and detachment of the cells (Fig. 3A) . To investigate whether the rounded cells observed in samples infected at high MOI died by apoptosis or necrosis, propidium iodide (PI) and annexin-V double-labeling assays were performed. From the samples infected at MOI of 10 and 50, 41 and 73%, respectively, stained double positive for PI and annexin-V-FITC (Fig. 3B) , suggesting that these cells died by necrosis (4) . The number of double-positive cells was not increased in samples infected at a MOI of 5 compared to the uninfected control (Fig. 3B) . In no case did we observe annexin-V-positive, PInegative cells, which would be typical for apoptotic cells (4). Therefore we infected at a MOI of 5 or less in further experiments. To determine whether the antiapoptotic effect depends on the stage of infection, apoptosis was induced 12, 24, 36, and 48 h postinfection. Double staining with Hoechst and an antichlamydia antibody demonstrated inhibition of apoptosis already at 24 h postinfection. However, the resistance to apoptosis at this time point correlated with the size of the inclusion in that generally cells harboring inclusions of 4 m in diameter or larger were protected, whereas cells with smaller inclusions frequently underwent apoptosis, similar to uninfected cells. Also, infecting HEp-2 cells with either 1, 3, or 5 bacteria per cell resulted in an apparent increase of rescued cells at a given time point. Additionally, at higher MOI more cells carried inclusions larger than 4 m, suggesting that increasing the dose of infection led to a critical bacterial load in more cells than infections at lower MOI (Fig. 3C) . Based on these results, for all subsequent experiments we chose to determine antiapoptotic effects 36 h postinfection in cultures infected at a MOI of 1, 3, or 5.
Epithelial cells infected with C. pneumoniae are resistant to TNF-␣-induced apoptosis. The pathway leading to apoptosis induced by staurosporine differs from the one engaged via the TNF-␣ receptor (TNF-R). Since HEp-2 cells express the TNF-R on their surfaces (4), we used these cells to investigate whether infection blocks apoptosis induced via the TNF-R. Uninfected cells were treated with 2 g of cycloheximide/ml and 40 ng of TNF-␣/ml. Cycloheximide has been shown to suppress survival signals induced by an engagement of TNF-R; thus we used it for efficient induction of apoptosis (18) . Six hours after stimulation, about 60% of uninfected control cells displayed typical features of apoptotic cells, whereas the infected cells were unaffected by apoptosis, similar to the untreated control cells (Fig. 1A) . However, the protection from apoptosis was restricted to the cells harboring inclusions, as uninfected cells present in the inoculated cultures underwent apoptosis (Fig. 1A) . Quantification showed that the inhibition of apoptosis in infected versus uninfected cells is significant (P ϭ 0.027) (Fig. 1B) . 
Lack of caspase-3 activation in infected cells.
To further analyze the mechanism of apoptosis inhibition occurring during infection with C. pneumoniae, we determined whether the block takes place upstream or downstream of caspase-3 activation. Caspase-3 has been implicated as a general effector of apoptosis that is activated via upstream caspases by a cleavage (21) . Staurosporine-treated infected and uninfected HEp-2 cells were subjected to immunostaining with a polyclonal antibody directed against the cleaved and activated form of caspase-3. Only uninfected cells and cells in the infected sample that carried no or small inclusions contained active caspase-3. In contrast, activated caspase-3 was absent in cells that contained chlamydial inclusions (Fig. 4) .
Inhibition of mitochondrial cytochrome c release in infected cells. During apoptosis, cytochrome c is rapidly released from the mitochondria and then initiates the activation of caspases in the cytosol (23) . To investigate whether TNF-␣-induced release of cytochrome c is blocked during infection with C. pneumoniae, infected and uninfected HEp-2 cells were treated with TNF-␣ in the presence of cycloheximide. Approximately 60% of the control cells released cytochrome c from the mitochondria, as revealed by the absence of cytochrome c staining in the cells (Fig. 5) . Within the inoculated culture, in the cells remaining uninfected or having inclusions smaller than 4 M cytochrome c was not detected (Fig. 5A ). In addition, these cells displayed apoptotic morphologies. In contrast, cells carrying inclusions larger than 4 M retained cytochrome c in the mitochondria and were protected from apoptosis (Fig. 5A) . Similar results were obtained by quantifying the amount of cytosolic cytochrome c by ELISA (Fig. 5B) . These data suggested, that C. pneumoniae blocks apoptosis in epithelial cells upstream of the mitochondrial cytochrome c release. (12, 24, 36 , and 48 h). Nuclei were stained with Hoechst 33342, and the apoptotic and nonapoptotic cells from the infected and uninfected specimens were counted in five random fields (total of more than 400 cells) under a fluorescence microscope (ϫ400 magnification). The plot shows the results of two independent experiments. Error bars, SD of the means.
DISCUSSION
Cells infected with viruses or bacteria frequently undergo apoptosis. Apoptosis in this context is an important antiviral or antibacterial response that prevents the spreading of the pathogen in the host (42) . The immune system very efficiently removes apoptotic cells including their harmful load even in the absence of a classical immune response. Therefore, apoptosis of the infected cell is of prime importance when the pathogens are hidden from the immune system, e.g., inside a cell. As a response to this host defense mechanism many viruses and obligate intracellular bacteria have developed strategies to prevent the self-destruction of their host cells. Among epithelial cells requires a soluble factor secreted by the infected host as the neighboring, uninfected epithelial cells were not protected from apoptosis, suggesting that the protective effect was exclusive for the cells inhabited by bacteria.
Our finding is not consistent with what has been shown earlier for inhibition of apoptosis in peripheral blood mononuclear cells infected with C. pneumoniae (14) , which could be due to the different types of cells used. It is possible that C. pneumoniae-mediated inhibition of apoptosis in the epithelium depends on a factor produced by chlamydial metabolically active forms (RB) and on the concentration of this factor. The latter could reflect the number of RB inside the inclusion because cells containing inclusions with diameters Ͻ4 M, thus likely having fewer bacteria, were not protected from apoptosis. From the view of C. pneumoniae this offers the advantage that successfully infected cells further support its growth and will not destroy themselves even if heavily infected.
We investigated the influence of C. pneumoniae on two different pathways of apoptosis induction in infected cells. Staurosporine, a cell-permeable potent inhibitor of several protein kinases, was used as inducer of intrinsic apoptotic pathways converging at mitochondria. The inducer of an extrinsic pathway was TNF-␣, which cross-links the TNF-R. We have shown that the infection with C. pneumoniae inhibited both staurosporine-and TNF-␣-induced apoptosis of epithelial cells. It is still a matter of debate whether receptor-initiated apoptosis requires mitochondrial function. At least in certain cell types this seems to be the case. In so-called type II cells, apoptosis is efficiently blocked by the overexpression of the Bcl-2 protein, an inhibitor of mitochondrial apoptosis (38) . If HEp-2 cells are of type II, C. pneumoniae might well prevent mitochondrial apoptosis, the simplest explanation for the effects we observed. There is also a possibility that the inhibitory mechanism in the infected cells is complex and operates on several levels.
An observation consistent with the infection-induced block of apoptosis at the mitochondrial level was the absence of significant alterations in the size or in the membrane potential of the mitochondria in TNF-␣-treated cells. For many pathways leading to apoptosis, the release of cytochrome c is the most essential upstream event for the activation of effector caspases (17, 25) . Cytochrome c was always retained in the mitochondria of the inclusion-carrying cells treated with TNF-␣. Thus, the mitochondria were completely protected and showed features of mitochondria typical for untreated cells. Consequently, active caspase-3 was not observed in cells infected with C. pneumoniae, as also shown for C. trachomatis (10) . We have so far no evidence that antiapoptotic proteins such as the Bcl-2 family are upregulated in infected epithelial cells. Moreover, the antiapoptotic nuclear factor B (NF-B) is not activated in HEp-2 cells at 20 h postinfection (H. Al-Younes, T. F. Meyer, and T. Rudel, unpublished data) although NF-B activation has been shown for endothelial cells and the smooth muscle cells infected with C. pneumoniae (9, 24) . However, it is still possible that other antiapoptotic host factors besides Bcl-2 and NF-B are induced by the pathogen.
Many viral and bacterial factors have been shown to interact at various checkpoints of the apoptotic machinery to modulate host cell apoptosis (28) . These include baculovirus protein p35 (6), a broad-range inhibitor of caspases, the caspase-8 and -1 inhibitor CrmA from cow pox virus, and the V-FLIPs, virally encoded proteins which interfere with receptor-initiated apoptosis (36) . Vpr-1 from human immunodeficiency virus targets mitochondria and prevents mitochondrial signaling probably in a manner similar to that of Bcl-2 (22) . Other bacterial factors target mitochondria to modulate apoptosis, such as the poreforming protein PorB from Neisseria (30) and a fragment of the vacuolating toxin VacA from Helicobacter pylori (13) . Thus, it is also possible that C. pneumoniae produces factors that interfere directly with the apoptotic machinery. Many gramnegative bacteria have evolved a highly specialized secretion apparatus to pump proteins into the host cell cytosol, the so-called type III secretion system (20) . Proteins injected by the type III system often interfere with host cell signaling (12, 26) . A putative locus of the type III secretion apparatus has recently also been identified in the chlamydial genome, and this enables us to speculate that the factor(s) responsible for blocking apoptosis may be a chlamydial protein secreted into the host cell cytosol by the type III secretion apparatus (11, 19) .
As C. trachomatis has also been shown to block apoptosis of infected host cells, this phenomenon seemed to be a common strategy developed by Chlamydiaceae. Evidently, obligate intracellular organisms benefit from the survival of their hosts. An apoptosis resistance pattern described in this work would also allow the pathogen to escape the antigen-specific immune effector mechanisms, most importantly cytotoxic T-lymphocytemediated killing of infected cells (32) . In agreement with intracellular survival strategies is also the down-regulation of major histocompatibility complex class I expression induced by C. pneumoniae in an infected macrophage cell line (5), which would prevent the antigen-specific immune response directed against the infected cell. In summary, C. pneumoniae exploits many ways to carve a safe niche within its host. Identification of bacterial factors will not only enable us to define the pathogenesis of chlamydial infection but might also lead to a deeper understanding of the central mechanisms of host cell apoptosis.
